What happens at a longevity festival?

Revolution Medicines' pancreatic cancer drug has not yet been approved — and already talk has shifted to how (and when) its use might be expanded.

“One of the cancer community’s worst fears is coming to pass,” writes Gwen Nichols of Blood Cancer United.

Ambient scribes were the first large-scale application of AI in health care. Now developers are pitching them as diligent note-takers for patients.

An oncologist shares three lessons from the world’s first randomized trial on a multi-cancer early detection.